VYOME HOLDINGS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$192.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- VYOME HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$102.81K.
- VYOME HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$89.19K, a 166.64% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $213.76K.
- VYOME HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $217.95K, a 1076.28% increase year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $434.57K.
- VYOME HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$64.46K, a 137.48% decline from fiscal 2023.
- VYOME HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $172.00K.
- VYOME HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.14M, a 1601.32% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$102.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$192.00K 10-Q · filed 2026-08-12 | $21.76K derived: sum of 3 quarters · filed 2026-08-12 | $239.71K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | -$89.19K 10-Q · filed 2026-05-12 | $124.57K derived: sum of 2 quarters · filed 2026-05-12 | $342.52K derived: sum of 3 quarters · filed 2026-05-12 | $211.53K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $213.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $431.71K derived: sum of 2 quarters · filed 2026-03-18 | $300.72K derived: sum of 3 quarters · filed 2026-08-12 | $434.57K 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $217.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $86.97K derived: sum of 2 quarters · filed 2026-08-12 | $220.81K 10-Q · filed 2025-11-14 | $156.46K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$130.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.86K 10-Q · filed 2026-08-12 | $359.00K 10-Q · filed 2025-08-14 | -$61.49K derived: sum of 3 quarters · filed 2026-08-12 | -$42.96K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $133.84K 10-Q · filed 2026-05-12 | $66.00K 10-Q · filed 2025-05-20 | $69.49K derived: sum of 2 quarters · filed 2026-05-12 | $88.02K derived: sum of 3 quarters · filed 2026-05-12 | $22.38K derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | -$64.35K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$45.82K derived: sum of 2 quarters · filed 2026-03-18 | -$111.46K derived: sum of 3 quarters · filed 2026-03-18 | -$64.46K 10-K · filed 2026-03-18 | $11.00K 10-K · filed 2025-04-04 | |||
| 2024-09-30 | $18.53K derived: 10-Q 9 month − 8-K 6 month · filed 2025-11-14 | -$47.11K derived: sum of 2 quarters · filed 2025-11-14 | -$113.00 10-Q · filed 2025-11-14 | -$119.00K 10-Q · filed 2024-11-14 | -$157.11K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | -$65.64K derived: 8-K 6 month − 10-Q 3 month · filed 2025-09-02 | -$18.64K 8-K · filed 2025-09-02 | -$31.00K 10-Q · filed 2024-08-14 | -$175.64K derived: sum of 3 quarters · filed 2025-09-02 | -$316.64K derived: sum of 4 quarters · filed 2025-09-02 | |||
| 2024-03-31 | $47.00K 10-Q · filed 2025-05-20 | -$110.00K derived: sum of 2 quarters · filed 2025-05-20 | -$251.00K derived: sum of 3 quarters · filed 2025-05-20 | -$146.00K derived: sum of 4 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | -$157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | -$298.00K derived: sum of 2 quarters · filed 2025-04-04 | -$193.00K derived: sum of 3 quarters · filed 2025-04-04 | $172.00K 10-K · filed 2025-04-04 | ||||
| 2023-09-30 | -$141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$36.00K derived: sum of 2 quarters · filed 2024-11-14 | $329.00K 10-Q · filed 2024-11-14 | -$116.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $470.00K 10-Q · filed 2024-08-14 | $25.00K derived: sum of 3 quarters · filed 2024-08-14 | -$318.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $365.00K 10-Q · filed 2024-05-15 | -$80.00K derived: sum of 2 quarters · filed 2024-05-15 | -$423.00K derived: sum of 3 quarters · filed 2024-05-15 | -$913.00K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$445.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$788.00K derived: sum of 2 quarters · filed 2024-04-01 | -$1.28M derived: sum of 3 quarters · filed 2024-04-01 | -$1.14M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$833.00K derived: sum of 2 quarters · filed 2023-11-09 | -$696.00K 10-Q · filed 2023-11-09 | -$703.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$490.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$353.00K 10-Q · filed 2023-08-07 | -$360.00K derived: sum of 3 quarters · filed 2023-08-07 | -$241.00K derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | $137.00K 10-Q · filed 2023-05-15 | $130.00K derived: sum of 2 quarters · filed 2023-05-15 | $249.00K derived: sum of 3 quarters · filed 2023-05-15 | $450.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$7.00K derived: 10-K 12 month − 10-K 9 month · filed 2023-04-17 | $112.00K derived: sum of 2 quarters · filed 2023-04-17 | $313.00K derived: sum of 3 quarters · filed 2023-04-17 | $76.00K 10-K · filed 2023-04-17 | $393.00K 10-K · filed 2022-04-08 | |||
| 2021-09-30 | $119.00K derived: 10-K 9 month − 10-K 6 month · filed 2023-04-17 | $320.00K derived: sum of 2 quarters · filed 2023-04-17 | $83.00K 10-K · filed 2023-04-17 | $399.00K 10-Q · filed 2021-11-12 | -$147.00K derived: sum of 4 quarters · filed 2023-04-17 | |||
| 2021-06-30 | $201.00K derived: 10-K 6 month − 10-Q 3 month · filed 2023-04-17 | -$36.00K 10-K · filed 2023-04-17 | $267.00K 10-Q · filed 2021-08-16 | -$266.00K derived: sum of 3 quarters · filed 2023-04-17 | -$969.00K derived: sum of 4 quarters · filed 2023-04-17 | |||
| 2021-03-31 | -$237.00K 10-Q · filed 2022-05-23 | -$467.00K derived: sum of 2 quarters · filed 2022-05-23 | -$1.17M derived: sum of 3 quarters · filed 2022-05-23 | |||||
| 2020-12-31 | -$230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$933.00K derived: sum of 2 quarters · filed 2022-04-08 | -$843.00K 10-K · filed 2022-04-08 | |||||
| 2020-09-30 | -$703.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$613.00K 10-Q · filed 2021-11-12 | ||||||
| 2020-06-30 | $90.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |